Related Experiment Videos
Cisplatin-associated hemolytic uremic syndrome
C Canpolat1, P Pearson, N Jaffe
1Division of Pediatrics, M. D. Anderson Cancer Center, Houston, Texas 77030.
Cancer
|December 1, 1994
Summary
Hemolytic uremic syndrome (HUS) can be a complication of cisplatin chemotherapy. This review examines HUS development in patients treated with chemotherapy agents, including cisplatin.
Area of Science:
- Oncology
- Nephrology
- Pediatrics
Background:
- Hemolytic uremic syndrome (HUS) is a triad of microangiopathic hemolytic anemia, acute renal failure, and thrombocytopenia.
- While often affecting children, HUS etiology is diverse, including infections and chemotherapy agents like cisplatin.